Eon: LL-37 2mg | EGCG 250mg (Inclusion Complexed) | Quercetin 250mg (Inclusion Complexed)

Name: Eon: LL-37 2mg | EGCG 250mg (Inclusion Complexed) | Quercetin 250mg (Inclusion Complexed) | Cellgenic
Price: 420.00 USD
Availability: InStock

What is Eon LL-37 Complex?

A comprehensive antimicrobial and immune modulation formulation combining LL-37 cathelicidin with enhanced EGCG and Quercetin. This synergistic blend provides broad-spectrum pathogen clearance, immune rebalancing, mucosal barrier repair, and anti-senescence effects for chronic infections, autoimmune conditions, and post-viral recovery.

Eon LL-37 2mg | EGCG 250mg (Inclusion Complexed) | Quercetin 250mg (Inclusion Complexed)

EXTENDED PROTOCOL

LL-37:

Cationic antimicrobial peptide derived from cathelicidin (hCAP18). Disrupts bacterial, viral, and fungal membranes; effective against biofilms. Activates Toll-like receptors (TLR2, TLR9) and enhances chemotaxis of immune cells. Promotes angiogenesis and epithelial regeneration.

EGCG (Inclusion Complexed):

Polyphenol from green tea with enhanced bioavailability via cyclodextrin inclusion. Scavenges ROS and chelates metals; activates Nrf2. Suppresses NF-κB, IL-6, and TNF-α; reduces mast cell activation. Blocks viral entry and replication; interferes with bacterial quorum sensing.

Quercetin (Inclusion Complexed):

Flavonoid with enhanced absorption via cyclodextrin inclusion. Stabilizes mast cells, reducing histamine, prostaglandins, and leukotrienes. Inhibits NF-κB, COX-2, iNOS; acts as a zinc ionophore. Senolytic properties: clears senescent cells and suppresses SASP.

Synergistic Integration:

Multi-pathway pathogen kill, superior biofilm eradication, balanced immune response, mucosal resilience, chronic inflammation suppression, and tissue longevity through complementary mechanisms.

Strategic Applications:

Post-viral recovery (EBV, COVID) – viral clearance, immune regulation, anti-fibrosis.
MCAS / Histamine intolerance – mast cell stabilization and histamine burden reduction.
Autoimmune support (Hashimoto’s, lupus) – Treg upregulation + NF-κB suppression + barrier healing.
Gut/Lung Barrier Dysfunction – epithelial repair + inflammation control.
Chronic Infections (Lyme, Candida, SIBO) – biofilm destruction + antimicrobial + cytokine modulation.
Anti-aging & Inflammaging – senolytic + regenerative + anti-fibrotic effects.

Dosage & Administration:

25–100 IU via subcutaneous (SC), intramuscular (IM), or intravenous (IV) route. Frequency: 1–2 times per week.

Cycle Length:

2–4 weeks for antimicrobial effect or immune priming. Can be repeated depending on infection load or immune dysregulation status.

Clinical Applications:

Broad-spectrum antimicrobial action, immune priming & modulation, inflammation control & barrier protection, post-infection recovery, and anti-aging & inflammaging support.

Monitoring Parameters:

Inflammatory markers: CRP, IL-6, TNF-α. Immune profile: WBC differential, Treg/Th17 balance. Clinical outcomes: infection clearance, symptom regression, mucosal/gut health.

Especially valuable for patients with chronic infections, autoimmune conditions, and post-viral recovery needs.

Mechanistic Pathways:

Antimicrobial – Multi-pathway pathogen disruption and biofilm eradication
Biofilm Disruption – Superior matrix breakdown and adhesion inhibition
Immune Modulation – TLR activation, Treg boost, mast cell stabilization
Barrier Protection – Epithelial restoration, tight junction support, mucosal resilience
Anti-Inflammatory – NF-κB suppression, Nrf2 activation, endotoxin neutralization
Senescence/Aging – Tissue regeneration, fibrosis reduction, senolytic activity

Testimonies

Promising Clinical Advances

Our clinical trials with Cellgenic Lyophilized Exosomes have shown promising results in orthopedic regenerative therapies.

John Carter

Regenerative Medicine Researcher

Improved Outcomes

Patients report less pain and increased functionality post-treatment, which is a big win in physical therapy.

Kathie Corl

Rehabilitation Specialist

Faster and Stronger Returns

I’ve been using Cellgenic Lyophilized Exosomes for my athletes suffering from ligament injuries. The recovery process has not only sped up but also strengthened the tissues around the injuries.

John Carter

Sports Medicine Doctor

Quicker Healing Post-Surgery

After integrating Cellgenic Lyophilized Exosomes into our post-surgical recovery protocols, we’ve observed significantly improved healing times and reduced inflammation in our patients.

Kathie Corl

Orthopedic Surgeon

Frequently asked questions

Gain insights on the uses, benefits, and guidelines for Cellgenic Lyophilized Exosomes Orthopedics

Cellgenic’s cellular products aim to provide various biological effects, including anti-inflammatory, regenerative, and immunomodulatory properties. These benefits are intended to assist in the recovery and improvement of various medical conditions.

Cellgenic’s products are designed for medical professionals only, including licensed physicians and healthcare institutions. These products must be administered by individuals who are trained and authorized to use cellular therapies.

Packages vary depending on the specific product but generally include the cellular product in a suitable formulation, along with necessary diluents or other components required for the application of the therapy.

These products work by promoting cell-to-cell communication, enhancing cellular functions, and providing necessary growth factors, cytokines, and other bioactive molecules to support tissue repair and regeneration.

Yes, interested buyers must have their account verified and activated by Cellgenic. This process includes confirming the credentials of the healthcare professionals and ensuring compliance with applicable regulations before purchases can be made.